Acuta Capital Partners’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-6,700
Closed -$136K 52
2022
Q3
$136K Buy
+6,700
New +$136K 0.06% 40
2022
Q2
Sell
-37,500
Closed -$717K 50
2022
Q1
$717K Buy
+37,500
New +$717K 0.34% 34